141
A Phase 1 Study of HLX20, a Human Monoclonal Antibody Targeting PD-L1Protein in Patients With Advanced Solid Tumors
Condition(s):Advanced Solid TumorsLast Updated:September 4, 2018Unknown status
Monoclonal Antibody: 6773 Clinical Trials, Page 15 of 678
Hide Studies Not Open or Pending
142
Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid Malignancies
Condition(s):Leukemia; Myelodysplastic SyndromeLast Updated:February 26, 2015Completed
143
An Exploratory Study of the Effects of a Single Dose of QAX576 (an Interleukin-13 Monoclonal Antibody) on Simulated Hayfever
Condition(s):Allergic RhinitisLast Updated:February 24, 2017Completed
144
Single Ascending Doses Study of Anti- Interleukin-7 Receptor α Monoclonal Antibody (GSK2618960) in Healthy Volunteers
Condition(s):Autoimmune DiseasesLast Updated:May 9, 2017Completed
145
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
Condition(s):Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:June 28, 2016Completed
146
Study of the Clinical Effectiveness of a Human Monoclonal Antibody to C. Difficile Toxin A and Toxin B in Patients With Clostridium Difficile Associated Disease
Condition(s):Clostridium InfectionsLast Updated:February 9, 2021Completed
147
Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer
Condition(s):Uterine Cervical Neoplasms; Cervical Cancer; Cervical Neoplasms; Cervix CancerLast Updated:September 20, 2019Unknown status
148
Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma
Condition(s):NeuroblastomaLast Updated:May 16, 2022Completed
149
VRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected…
Condition(s):HIV-1 Infection; Neutralizing Antibody; Monoclonal Antibody; Viral Load; HIV AntibodiesLast Updated:December 17, 2019Completed
150
Study of the CD40 Agonistic Monoclonal Antibody APX005M
Condition(s):Cancer; NSCLC; Melanoma; Urothelial Carcinoma; MSI-H; Head and Neck CancerLast Updated:April 28, 2020Completed